Puma Biotechnology, Inc.PBYINASDAQ
Loading
Net Income PerformanceStrong
Percentile Rank100
3Y CAGR+2395.3%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+2395.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
15536.5x
Strong expansion
Streak
8 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$31.07M+2.6%
2024$30.28M+40.2%
2023$21.59M+1079450.0%
2022$2000.00+100.0%
2021$-29.13M+51.5%
2020$-59.99M+20.6%
2019$-75.59M+33.5%
2018$-113.60M+61.1%
2017$-292.00M-5.8%
2016$-276.00M-